Supplementary Methods 1 from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition

作者：Max Schlaak, Carolina Cimminiello, Jacopo Pigozzo, Jeeyun Lee, Stephan Grabbe, Piotr Rutkowski, Jacek Mackiewicz, Katy K. Tsai, Paolo A. Ascierto, Mario Mandalà, Fabrizio Carnevale‐Schianca, Sebastian Haferkamp, Victoria Atkinson, Jessica C. Hassel, Shahneen Sandhu, William H. Sharfman, Emma Dean, Urwah Noor, Sonia Iyer, Roy Rabbie, Antoni Ribas · 年份：2026 · DOI：10.1158/1078-0432.33014435 · 研究领域：Medicine、Internal medicine、Oncology、Cancer research

<p>Study treatment discontinuation criteria and Flow Cytometry Immunophenotyping.</p>